
Lakefront Biotherapeutics N.V. (LKFT) earnings
- Healthcare
- NASDAQ
- Market cap$2.2B
Next report
2027-02-24
In 95 daysQ4 FY2026Time not announced· Expected date
- EPS consensus
- -0.70
- Revenue consensus
- $7.96M
Latest result
10 days ago+94.6%
Unusually large: likely a one-off gain or charge, so not comparable with consensus
2026-11-11Q3 FY2026
- EPS
- Reported / estimate-0.04 / -0.83
- Revenue
- $8.39M / $7.50M
Stock reaction
Unavailable
Recent quarters
Latest 2 quartersRevenue and stock reaction
| Quarter | EPSReported / estimate | RevenueReported / estimate | Reaction |
|---|---|---|---|
Q3 FY2026 2026-11-11 | -0.04 / -0.83 +94.6%† | $8.39M / $7.50M | Unavailable |
Q2 FY2026 2026-08-10 | 0.03 / -0.24 +114.6%†¶ | $14.0M / $6.20M | Unavailable |
Reported / estimate
- Q3 FY2026 · 2026-11-11UnavailableEPS-0.04 / -0.83+94.6%†Revenue$8.39M / $7.50M
- Q2 FY2026 · 2026-08-10UnavailableEPS0.03 / -0.24+114.6%†¶Revenue$14.0M / $6.20M
- †Unusually large: likely a one-off gain or charge, so not comparable with consensus
- ¶Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.
This company reports in EUR, and its reported revenue and the estimate may be in different currencies, so no revenue surprise or dollar sign is shown.
Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.